University of California San Francisco
Give to UCSF
T cells – immune cells that patrol our bodies in search of trouble – have become a central focus for UC San Francisco scientists working on living cell therapies, an approach that views cells
Scientists at UCSF are learning how immune cells naturally clear the body of defunct – or senescent – cells that contribute to aging and many chronic diseases
For some people a sales ban that takes the temptation out of the workplace may not be enough.
A generous gift of $1 million from an anonymous donor recently created the Breakthrough Initiative in Type 1 Diabetes Precision Medicine and Discovery.
Researchers at UCSF have developed a “digital biomarker” that would use a smartphone’s built-in camera to detect diabetes.
UCSF Medical Center has been recognized as one of the nation’s finest hospitals in the U.S. News & World Report 2020-2021 Best Hospitals survey, ranking among the top 10 hospitals nationwide for the 22nd year.
The annual U.S. News rankings serve as a guide of hospitals nationwide that excel in treating children with the most challenging diagnoses.
We asked a team of UCSF kidney experts – including nephrologist, a transplant surgeon, a transplant pharmacist and a bioengineer – to shine a light on the problem of kidney disease and share their hopes for the future.
UCSF researchers have partnered with local government agencies on an ongoing project that is installing hydration stations in low-income communities in San Francisco, parts of the city where conditions like diabetes, obesity, and heart disease disproportionately affect minority populations.
With the global population of seniors projected to reach 1.5 billion by 2050, it will be more important than ever to reduce the burden of age-related disease. In the future, science will allow us to intervene in the aging process to make this a reality, according to geriatrician John Newman.
A future in which precision medicine benefits everyone is not guaranteed. For that to happen, UCSF experts argue, the health care industry must first tackle today’s health disparities, including differences in disease outcomes and access to care based on race, gender, and socioeconomic status.
Browse the stories that most engaged our readers in 2019.
UCSF physician Peter Ganz and colleagues at Colorado-based SomaLogic Inc., are developing what they call “liquid health check” technology – a single blood test capable of painting a detailed portrait of a person’s current health and future disease risks.
